Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRONOS: Ceftriaxone Prophylaxis vs No Prophylaxis in HSCT
NCT07308457Recruiting
- Sponsor
- Pomeranian Medical University in Szczecin
- Start
- Sep 2024
- Primary completion
- Jun 2027
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of ceftriaxone in infectious diseases (2 arms), sponsored by Pomeranian Medical University in Szczecin. Primary endpoint: Incidence of infections. Started Sep 2024; status: recruiting.
02
Drugs
ceftriaxone
03
Conditions
infectious diseases
Beyond the preview
Go deeper on NCT07308457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07308457.